拥有“国家级绝密配方”的云南白药,增长停滞

砺石商业评论
05 Nov 2024

全文3374字,阅读约需10分钟,帮我划重点划重点01云南白药2024年三季度财报显示,公司前三季度实现营业总收入299.2亿元,同比增长0.76%,净利润43.27亿元,同比增长4.93%。02然而,云南白药第三季度净利润同比下滑12.16%,主要原因在于炒股收益的大幅缩水。03为摆脱炒股依赖,云南白药决定聚焦主业,同时发力创新药研发,调整组织架构,聚焦药品、健康品、中药资源等四大事业群。04...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10